Neutrophil-lymphocyte ratio (NLR) as an important prognostic factor for paclitaxel as a second line chemotherapy in advanced gastric cancer (AGC): Results from phase III DREAM study

  • Ryu, M-H.; 
  • Kim, J. H.; 
  • Oh, S. C.; 
  • Park, S.; 
  • Kim, J. G.; 
  • 외 4명
제목
Neutrophil-lymphocyte ratio (NLR) as an important prognostic factor for paclitaxel as a second line chemotherapy in advanced gastric cancer (AGC): Results from phase III DREAM study
저자
Ryu, M-H.; Kim, J. H.; Oh, S. C.; Park, S.; Kim, J. G.; Kim, J. W.; Cho, S-H.; Yoon, K-E.; Kang, Y-K.
DOI
10.1093/annonc/mdy282.073
발행일
2018-10
학회명
43rd ESMO Congress (ESMO)
개최지
Munich, GERMANY
개최국가
영국
학회 개최일
2018-10-19 ~ 2018-10-23